Dr. Avanzi most recently served as vice president of clinical development at Neogene Therapeutics, according to a Feb. 21 release announcing his appointment. While at Neogene, he oversaw clinical studies on TCR T cells targeting neoantigens.
Dr. Avanzi has also held a variety of positions at Kite Pharma, including medical director and senior medical director before serving as executive medical director from 2020 to 2021, according to LinkedIn.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
